002821.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:04):

Stats
Dzisiejszy wolumen	4.02M
Średni wolumen	5.61M
Kapitalizacja rynkowa	29.62B
EPS	CNY0 ( 2024-04-26 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	15.59
ATR14	CNY0.0530 (0.06%)

Wolumen Korelacja

Długi: -0.02 (neutral)

Krótki: -0.91 (very strong negative)

Signal:(29.148) Possible Trading Opportunity Present (swing)

Asymchem Laboratories Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Asymchem Laboratories Korelacja - Waluta/Towar

0.01
( neutral )

-0.44
( neutral )

0.00
( neutral )

-0.40
( neutral )

0.68
( moderate )

Asymchem Laboratories Finanse

Annual	2023
Przychody:	CNY7.75B
Zysk brutto:	CNY3.80B (49.05 %)
EPS:	CNY6.26

FY	2023
Przychody:	CNY7.75B
Zysk brutto:	CNY3.80B (49.05 %)
EPS:	CNY6.26

FY	2022
Przychody:	CNY10.26B
Zysk brutto:	CNY4.86B (47.37 %)
EPS:	CNY9.02

FY	2021
Przychody:	CNY4.64B
Zysk brutto:	CNY2.06B (44.33 %)
EPS:	CNY4.56

Financial Reports:

No articles found.

Asymchem Laboratories

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.